COMMUNIQUÉS West-GlobeNewswire
      -   
  
Tetra Bio-Pharma Inc. Provides Corporate Update Ahead of Its Annual General Meeting
13/06/2018 -   
  
Corium Announces Issuance of Key U.S. Patent Covering Corplex™ Donepezil Transdermal System for Alzheimer’s Disease
13/06/2018 -   
  
Metacrine Completes Dosing of First Cohort in Phase 1 Trial of MET409, a Novel Non-Bile Acid FXR Agonist
13/06/2018 -   
  
Biogen Enhances Commitment to SMA Research with Data Presented at Annual SMA Conference
13/06/2018 -   
  
Assembly Biosciences to Host Research and Development Day on Wednesday, June 20, 2018
13/06/2018 -   
  
Medtronic Launches New Clinician Programmer for Deep Brain Stimulation Therapy
13/06/2018 -   
  
Revive Therapeutics and WeedMD Sign Medical Cannabis R&D Supply and Collaboration Agreements
13/06/2018 -   
  
Ceapro Announces Data from Avenanthramides Study Presented at the Nutrition 2018 Meeting
13/06/2018 -   
  
Akcea Announces Completion of Landmark Study to Assess Disease Burden in People Living with FCS
13/06/2018 -   
  
Leap Therapeutics to Present at the 2018 JMP Securities Life Sciences Conference
13/06/2018 -   
  
BioCryst Pharmaceuticals and Idera Pharmaceuticals to Present at the JMP Securities Life Sciences Conference
13/06/2018 -   
  
PetVivo Holdings, Inc. Adds Dr. Tracy Turner, Creates Veterinary Advisory Board
13/06/2018 -   
  
Late-Breaking Data and Clinician Reviews on Now FDA-cleared T2Bacteria Panel Underscore Sepsis Prevention Opportunities at ASM Microbe 2018
13/06/2018 -   
  
Avivagen Announces Distribution Agreement in Thailand
13/06/2018 -   
  
Wright Medical Group N.V. Announces FDA Premarket Approval for AUGMENT® Injectable Bone Graft
13/06/2018 -   
  
Japanese Medical Agency (PMDA) supports the expansion of the Phase III program for PledOx® to include Japanese patients
13/06/2018 -   
  
Orion to join John Nurminen Foundation's Clean Baltic Sea projects as a new main partner
13/06/2018 -   
  
Herantis Pharma announces initiation of Phase 2 study for Lymfactin® gene therapy in secondary lymphedema
13/06/2018 -   
  
Shire plc : Rule 2.9 Announcement
13/06/2018 
Pages